Patents by Inventor Arjun Saha

Arjun Saha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11516624
    Abstract: An indoor location positioning system comprises at least one processor, Wi-Fi scanners, and a RSSI fingerprint database. The Wi-Fi scanners and the RSSI fingerprint database works with the processor. The Wi-Fi scanners are positioned at locations within an environment that is partitioned into interconnected zones. The Wi-Fi scanners receive anonymous probe messages from Wi-Fi devices that are present in the environment during a calibration phase of the indoor location positioning system. The RSSI values are collated to create RSSI fingerprints corresponding to the different locations respectively. One or more of the Wi-Fi scanners are used as anchor scanners to counter the difference in transmit power levels of different Wi-Fi devices that result in different RSSI fingerprints for the different types of Wi-Fi devices, wherein the RSSI value at each anchor scanner is subtracted from the RSSI values at rest of the Wi-Fi scanners to generate the RSSI fingerprint.
    Type: Grant
    Filed: March 2, 2021
    Date of Patent: November 29, 2022
    Assignee: HUGHES SYSTIQUE PRIVATE LIMITED
    Inventors: Abheek Saha, Mayank Maheshwari, Arjun Roychowdhury
  • Patent number: 11278575
    Abstract: The present disclosure provides compositions and methods for treating demyelinating conditions. More particularly, the present disclosure relates to compositions including DUOC-01 cell product and an anti-inflammatory agent; methods for preparing such compositions; and methods of using such compositions in combination or in conjunction with each other for treatment of treating demyelinating conditions.
    Type: Grant
    Filed: July 12, 2019
    Date of Patent: March 22, 2022
    Assignee: Duke University
    Inventors: Joanne Kurtzberg, Andrew E. Balber, Arjun Saha, Pamela Noldner, Paula Scotland
  • Publication number: 20210275583
    Abstract: The present disclosure provides compositions and methods for treating demyelinating conditions. More particularly, the present disclosure relates to compositions comprising a DUOC-01 cell product; methods for preparing such compositions; and methods of using such compositions for treating demyelinating conditions.
    Type: Application
    Filed: May 24, 2021
    Publication date: September 9, 2021
    Applicant: Duke University
    Inventors: Joanne Kurtzberg, Anthony Fillano, Arjun Saha, Andrew E. Balber, Ana Valverde
  • Publication number: 20200038456
    Abstract: The present disclosure provides compositions and methods for treating demyelinating conditions. More particularly, the present disclosure relates to compositions including DUOC-01 cell product and an anti-inflammatory agent; methods for preparing such compositions; and methods of using such compositions in combination or in conjunction with each other for treatment of treating demyelinating conditions.
    Type: Application
    Filed: July 12, 2019
    Publication date: February 6, 2020
    Inventors: Joanne Kurtzberg, Andrew E. Balber, Arjun Saha, Pamela Noldner, Paula Scotland
  • Publication number: 20190350985
    Abstract: The present disclosure relates to methods of treating cerebral palsy and hypoxic-ischemic brain injury. More particularly, the present disclosure relates to methods of using cord blood or components thereof to treat cerebral palsy and hypoxic-ischemic brain injury. The present disclosure also relates to methods of assessing neuroprotective activity of a neuroprotective agent.
    Type: Application
    Filed: January 12, 2018
    Publication date: November 21, 2019
    Inventors: Joanne Kurtzberg, Jessica Sun, Ana Valverde Vidal, Jesse Troy, C. Michael Cotten, Andrew Balber, Daniel Laskowitz, Arjun Saha
  • Publication number: 20190343882
    Abstract: The present disclosure provides compositions and methods for the treatment of demyelinating conditions. More particularly, the present disclosure relates to compositions including DUOC-01 cell product, derived from banked human umbilical cord blood (CB) mononuclear cells; methods for preparing such compositions; and methods of using such compositions for treatment of demyelinating conditions.
    Type: Application
    Filed: January 12, 2018
    Publication date: November 14, 2019
    Inventors: Joanne Kurtzberg, Andrew E. Balber, Arjun Saha, Pamela Noldner, Paula Scotland